Literature DB >> 633597

Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.

C Kawai, A Matsumori, N Kumagai, M Tokuda.   

Abstract

Mice were inoculated with recently isolated Coxsackie virus B-3 and B-4 intraperitoneally. Severest lesions in the hearts were observed in mice between the age of 7 and 14 days. Grossly yellow-white patches were seen on the hearts of mice from the 7th day to the 6th month after virus inoculation. Microscopically, the heart showed extensive myocardial necrosis, inflammation with small mononuclear cells and calcification on the day of 7. There were myocardial fibrosis and calcification at the 6th month after inoculation with Coxsackie virus B-3, and at the 3rd month after inoculation with Coxsackie virus B-4, but generally pathologic changes were less severe in the latter. Myocardial fibrosis in the present experiment was most prominent among the experiments we have studied. It was confirmed that chronic myocardial fibrosis follows acute Coxsackie virus myocarditis in mice. Possible role of Coxsackie virus myocarditis in the development of cardiomyopathy was briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 633597     DOI: 10.1253/jcj.42.43

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  11 in total

1.  Myocarditis: some current perspectives and future directions.

Authors:  H A McAllister
Journal:  Tex Heart Inst J       Date:  1987-12

2.  Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects.

Authors:  M A Beck; N M Chapman; B M McManus; J C Mullican; S Tracy
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Monoclonal anti-idiotypic antibodies regulate the expression of virus-induced murine myocarditis.

Authors:  R E Paque; R Miller
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 4.  Approaches to prevention and early detection of cardiomyopathies: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

Review 5.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Authors:  C J Gauntt; R E Paque; M D Trousdale; R J Gudvangen; D T Barr; G J Lipotich; T J Nealon; P S Duffey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.

Authors:  C J Gauntt; P T Gomez; P S Duffey; J A Grant; D W Trent; S M Witherspoon; R E Paque
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.

Authors:  R M Gómez; C G Castagnino; M I Berría
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

9.  Cardiomyopathy and myocarditis--a review of new aspects in research in West Germany.

Authors:  B Maisch; T Izumi
Journal:  Heart Vessels Suppl       Date:  1985

10.  Pancreatic uptake of 99Tc stannous pyrophosphate in experimental viral pancreatitis in mice.

Authors:  A Matsumori; K Kadota; C Kawai
Journal:  Eur J Nucl Med       Date:  1981-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.